What is the recommended treatment for Shigella infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Shigella Infections

For Shigella infections, ciprofloxacin is the first-line treatment for adults (500 mg twice daily for 3-7 days), while azithromycin is preferred for children (10 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days). 1

Treatment Recommendations by Population

Adults

  • First-line: Ciprofloxacin 500 mg twice daily for 3-7 days 1
  • Alternative options:
    • Trimethoprim-sulfamethoxazole (TMP-SMX) 160 mg TMP and 800 mg SMX twice daily for 5 days 1, 2
    • Azithromycin 500 mg once daily for 3 days 1
    • Nalidixic acid 55 mg/kg/day in four divided doses for 5 days 1
    • Tetracycline 50 mg/kg/day in four divided doses for 5 days 1

Children

  • First-line: Azithromycin 10 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days 1
  • Alternative option: Ceftriaxone 1
  • Note: Fluoroquinolones are not first-line for children due to concerns about arthropathy, though they can be used when necessary 1
  • TMP-SMX dosing for children: 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, given in two divided doses every 12 hours for 5 days 2

Special Populations

Immunocompromised Patients

  • HIV-infected patients may require extended treatment for up to 14 days 1
  • Patients with bacteremia may also need extended treatment for up to 14 days 1

Food Handlers and Healthcare Workers

  • May require follow-up stool culture to ensure clearance before returning to work 1

Treatment Considerations

Antibiotic Resistance

  • Multiresistant strains of Shigella are widespread globally 1
  • High rates of resistance to ampicillin and TMP-SMX have been reported 1
  • Increasing resistance to fluoroquinolones observed in some regions 1, 3
  • Ciprofloxacin remains effective in many regions with resistance rates as low as 2.6-7% across different Shigella species 3

Treatment Failure

  • If no clinical response occurs within 2 days, change to another recommended antibiotic 1
  • If no improvement after an additional 2 days, refer for stool microscopy 1

Practical Treatment Algorithm

  1. Identify patient age and risk factors
  2. For adults:
    • Start ciprofloxacin 500 mg twice daily for 3-7 days
    • If contraindicated or unavailable, use azithromycin or TMP-SMX
  3. For children:
    • Start azithromycin 10 mg/kg on day 1, followed by 5 mg/kg once daily for 4 days
    • If contraindicated or unavailable, consider ceftriaxone
  4. Monitor response:
    • Assess for clinical improvement within 48 hours
    • If no improvement, switch to alternative antibiotic
  5. Special considerations:
    • Extend treatment duration for immunocompromised patients or those with bacteremia
    • Consider local resistance patterns when selecting empiric therapy

Important Caveats

  • Mass prophylaxis or prophylaxis of family members is not recommended 1
  • Local susceptibility patterns should guide therapy choice, particularly for empiric treatment 1
  • Antibiotics should be avoided for STEC O157 and other Shiga toxin 2-producing E. coli infections, as antimicrobial therapy may increase the risk of hemolytic uremic syndrome (HUS) 1
  • Despite concerns about arthropathy with fluoroquinolones in children, studies have shown ciprofloxacin to be safe and effective in pediatric shigellosis when necessary 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.